Clinical Trials Browser

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

Clinical Trials

A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors

Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)

A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors

IMperator

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

SALIENT

A Study of ES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor

Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Absorption and Excretion of Oral Docetaxel

PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors

Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors

Study of PKI-179 Administered Orally to Subjects With Solid Tumors

A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

A Study of PTS for Patients With Solid Tumors

Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors

A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors

Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers

CryoSpray Ablation(tm)Thoracic Patient Registry

A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors